GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Fos | increases expression | EXP | | 6480464 | CTD | oxaliplatin results in increased expression of FOS mRNA | PMID:25729387 | Fos | multiple interactions | EXP | | 6480464 | CTD | [Oxaliplatin co-treated with Topotecan] results in increased expression of FOS mRNA; [SCH772984 co-treated with bilobalide] inhibits the reaction [Oxaliplatin promotes the reaction [Morphine results in increased expression of FOS protein]]; bilobalide inhibits the reaction [Oxaliplatin promotes the reaction [Morphine results in increased expression of FOS protein]]; Oxaliplatin promotes the reaction [Morphine results in increased expression of FOS protein]; SCH772984 inhibits the reaction [Oxaliplatin promotes the reaction [Morphine results in increased expression of FOS protein]] | PMID:25729387 PMID:32319158 | Fos | increases expression | ISO | Fos (Mus musculus) | 6480464 | CTD | oxaliplatin results in increased expression of FOS protein | PMID:24908156 | Fos | multiple interactions | ISO | Fos (Mus musculus) | 6480464 | CTD | Acetylcysteine inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; Quercetin inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; resveratrol inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; Rutin inhibits the reaction [oxaliplatin results in increased expression of FOS protein] | PMID:24908156 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |